Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiotherapy
Biotech
Nanobiotix finds new way to source cash from J&J-partnered drug
Nanobiotix is continuing to find fresh ways to eke money out of its Johnson & Johnson-partnered, phase 3-stage cancer drug.
James Waldron
Oct 31, 2025 6:05am
Shuttle Pharma launches into AI drug discovery via $10M buy
Oct 10, 2025 7:00am
Siemens Healthineers to move Varian manufacturing to California
May 14, 2025 10:30am
ESMO: Lantheus' radiotherapy readout not enough to best Pluvicto
Sep 16, 2024 8:55am
FDA sinks Actinium's radiotherapy blood cancer filing plans
Aug 5, 2024 8:12am
Novartis pays PeptiDream $180M as radiopharma big bang continues
Apr 30, 2024 4:12am
